CVAC
CureVac NV
NASDAQ: CVAC · HEALTHCARE · BIOTECHNOLOGY
$4.66
+0.00% today
Updated 2026-04-30
Market cap
$1.05B
P/E ratio
6.96
P/S ratio
14.83x
EPS (TTM)
$0.67
Dividend yield
—
52W range
$3 – $6
Volume
1.1M
CureVac NV (CVAC) Financial statements
SEC filings — annual and quarterly data.
Profit margin
182.10%
Operating margin
573.00%
ROE
40.20%
ROA
23.80%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2018 | $12.87M | $-71.24M | -37.86% | -565.80% | -553.50% |
| 2019 | $17.42M | $-99.87M | -60.67% | -571.30% | -573.46% |
| 2020 | $48.90M | $-129.07M | 71.02% | -253.58% | -263.96% |
| 2021 | $102.99M | $-411.72M | -131.28% | -400.29% | -399.76% |
| 2022 | $67.42M | $-249.03M | -172.91% | -370.00% | -369.37% |
| 2023 | $53.76M | $-260.17M | -131.34% | -510.08% | -483.96% |
| 2024 | $535.18M | $162.19M | 80.23% | 33.20% | 30.30% |